Insightec

Maurice R. Ferré MD is INSIGHTEC’S CEO and Chairman of the Board of Directors. Dr. Ferré brings over 20 years of experience in the medical device industry. Before INSIGHTEC, Dr. Ferré served as Chairman of the Board and CEO of MAKO Surgical Corp, a transformational robotic surgical company that he co-founded in 2004. The company was IPO’d in 2008 and recently sold to Stryker Corp. for $1.65 billion in 2013. Prior to MAKO, Dr. Ferré was Founder, CEO and President of Visualization Technology Inc. (1993-2002). VTI became the world leader in image guided surgery for ENT, cranial and orthopedic procedures. The Company was acquired by GE Healthcare in 2002. Dr. Ferré received his Doctor of Medicine and Master of Public Health from Boston University in 1992. He was also the recipient of the prestigious Ernest & Young 2007 Entrepreneur of the Year Award. Dr Ferre is currently active on the following boards: Advamed, The Everglades Foundation and Boston University.

Jacob “Kobi” Vortman is INSIGHTEC’s Vice Chairman of the Board. Kobi founded the company in 1999 and under his leadership, INSIGHTEC has been developing and marketing its Magnetic Resonance guided Focused Ultrasound (MRgFUS) technology. Prior to founding INSIGHTEC, Kobi served as President of Elbit Medical Imaging where he was responsible for the development of the proprietary MRgFUS technology that was passed to INSIGHTEC when it was established as a joint effort with Elbit Medical Imaging and GE Healthcare (formerly GE Medical Systems). GE Healthcare remains a major shareholder of the company until today. Previously Kobi served as President and Chief Executive Officer at Diasonics Vingmed Ultrasound and as General Manager at ElscinTEC. Twenty years prior, he worked with RAFAEL, holding many positions, including marketing, business development, operations and engineering roles. Kobi Vortman received his PhD in Electro Optics and a BSc in Electrical Engineering from the Technion, Israel Institute of Technology in Haifa. He also received a BSc in Physics and Mathematics from the Hebrew University of Jerusalem.

Eyal manages all activities in Israel and is a member of the executive management team. Eyal has been involved in research and development of multidisciplinary technology projects for more than 25 years. Eyal joined INSIGHTEC in 1999 and has held various positions in the R&D team, including software development, project leadership and product management positions. In 2001, Eyal was appointed to be INSIGHTEC’s Neuro Program Manager. In 2011, he was appointed VP of R&D, leading the company’s technology and innovation. Eyal holds a PhD in Computer Science from Tel Aviv University’s School of Mathematics and a BsC in Aeronautical Engineering (Cum Laude) from the Technion, Israel Institute of Technology.

Nadir Alikacem is INSIGHTEC’s Vice President of Global Regulatory Affairs and CRO. He is responsible for regulatory strategy, clinical research planning, research protocol coordination, working with all relevant regulatory bodies and managing the CRO activities. Prior to joining INSIGHTEC, Nadir was an Assistant Professor at UT southwestern Medical Center in Dallas, Texas. Previously, he was a Scientist at Saint Francois’ D’Assise Hospital in Quebec-City, Canada. Nadir Alikacem received his Postdoctoral fellowship in Physics from the University of Massachusetts at Amherst, Massachusetts. He received a PhD & MSc in Physics from the University of Sussex, England.